CG MedTech Co.,Ltd.

KOSDAQ:A056090 Stock Report

Market Cap: ₩124.3b

CG MedTechLtd Balance Sheet Health

Financial Health criteria checks 5/6

CG MedTechLtd has a total shareholder equity of ₩69.8B and total debt of ₩1.9B, which brings its debt-to-equity ratio to 2.7%. Its total assets and total liabilities are ₩87.1B and ₩17.3B respectively. CG MedTechLtd's EBIT is ₩2.6B making its interest coverage ratio 16.3. It has cash and short-term investments of ₩24.8B.

Key information

2.7%

Debt to equity ratio

₩1.90b

Debt

Interest coverage ratio16.3x
Cash₩24.76b
Equity₩69.82b
Total liabilities₩17.27b
Total assets₩87.10b

Recent financial health updates

Recent updates

Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

May 04
Does U&I (KOSDAQ:056090) Have A Healthy Balance Sheet?

We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

Jan 11
We Think U&I (KOSDAQ:056090) Has A Fair Chunk Of Debt

Financial Position Analysis

Short Term Liabilities: A056090's short term assets (₩43.3B) exceed its short term liabilities (₩7.5B).

Long Term Liabilities: A056090's short term assets (₩43.3B) exceed its long term liabilities (₩9.7B).


Debt to Equity History and Analysis

Debt Level: A056090 has more cash than its total debt.

Reducing Debt: A056090's debt to equity ratio has reduced from 71.4% to 2.7% over the past 5 years.

Debt Coverage: A056090's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: A056090's interest payments on its debt are well covered by EBIT (16.3x coverage).


Balance Sheet


Discover healthy companies